The following is a summary of “Machine learning for the prediction of mortality in patients with sepsis-associated acute ...

DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, ...

Chemotherapy regimen shows potential to improve survival and reduce need for surgery in patients with muscle-invasive bladder ...

Metablok is under clinical development by Arch Biopartners and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

SeaStar Medical (ICU) announces the shipment of its QUELIMMUNE device to a prominent academic medical center, representing SeaStar Medical’s ...

EA-230 is under clinical development by Exponential Biotherapies and currently in Phase II for Acute Inflammation.

TIN-816 is under development for the treatment of sepsis-associated acute kidney injury (SA-AKI) and acute kidney injury ...

QUELIMMUNE is the Company’s Selective Cytopheretic Device (SCD) for treating critically ill children in the intensive care unit (ICU) with acute kidney injury (AKI) and sepsis. “Within weeks ...

Main causes of AKI include sepsis, ischaemia-reperfusion injury and nephrotoxins. Symptoms include fatigue, loss of appetite, headache, nausea and vomiting. Early prediction of Acute kidney injury ...

Proenkephalin A 119-159 (penKid) demonstrates potential as a predictor for successful discontinuation of continuous renal replacement therapy (CRRT) in cardiac surgery patients.Study reveals ...

Abdominal pain in your upper or lower pelvis where your bladder sits could have a non-infectious cause. Learn what causes ...

A new mutation and the first severe case of H5N1 bird flu discovered in a human in Louisiana has raised concern among some ...